iRhythm Technologies

iRhythm Technologies is a leading digital healthcare company focused on the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services. The company's flagship Zio system combines wearable biosensing technology with cloud-based data analytics and proprietary machine-learning algorithms to detect, predict, and prevent cardiac arrhythmias. The company's platform, Zio by iRhythm, provides physicians with a more efficient and accurate way to diagnose arrhythmias compared to traditional Holter monitors. By offering long-term continuous monitoring (up to 14 days), iRhythm enables earlier medical intervention and helps avoid serious downstream events such as strokes. The company is publicly traded on the NASDAQ and has established a significant presence in the U.S. and international markets, including the UK and Japan.